REDCARE PHARMA revenue breakdown overview

REDCARE PHARMA revenue for the last year amounted to 2.37 B EUR, the most of which — 1.45 B EUR — came from its highest performing source at the moment, DACH, the year earlier bringing 940.17 M EUR. The greatest contribution to the revenue figure was made by Netherlands — last year it brought REDCARE PHARMA 1.37 B EUR, and the year before that — 11.63 M EUR.